Cancer constitutes one of the leading causes of mortality worldwide. As early diagnosis is paramount to improved clinical outcome and survival, sensitive diagnostics capable of detecting cancer-related molecules are necessary.
Despite technological advances, traditional methodologies such as ELISA assays are routinely used in clinical practice for diagnosis of cancer. However, these are time-consuming and suffer from low sensitivity, necessitating alternative clinically relevant solutions for early screening of individuals at high risk of cancer.
Further details: Biosensors for bladder cancer diagnosis